Body Contouring in Porto Alegre BR
Body Contouring in Porto Alegre section, includes general infrmation about Body Contouring Procedure, Body Contouring Porto Alegre Local News, Body Contouring Porto Alegre Surgeon Locator and other Body Contouring related material.
Porto Alegre Body Contouring - The Procedure
This procedure can help you to dramatically improve your appearance. It is usually the next step after excessive weight reduction or bariatric surgery. When you loose weight quickly your skin cannot return to the new size as quickly resulting in extra skin is areas such as the abdomen, upper arms, thighs and breasts. Sometimes your skin is not elastic enough due to aging process, which can lead to permanent skin flaps. It can also be done to repair the effects of childbearing and aging. The extra skin can cause hygiene problems, avoiding cloth with short sleeves and low self-esteem. Body contouring is a series of operation, which can be divided into two groups, lower body lift and upper body lift. The lower body lift deals with your abdomen thighs and buttocks. Upper body lift is complementary to the lower body lift and it deals with breast and upper arms. The ideal candidates for the surgery are people in good general health who are unsatisfied with their body appearance.
Porto Alegre Body Contouring - OperationDuring the surgery usually the abdomen is treated first, because it is the area with the most excess of skin and fat. A horizontal incision is made above the pubic area, through which the extra fat is removed and the muscles are tightened. In some cases liposuction is performed to remove extra fat. Thighs and butt are treated by the same principle. The operation lasts from 4-7 hours and performed under general anesthesia. Sometimes additional procedures are done during the same operation; those include breast lift, arm lift or inner thigh lift. Arm lift is done by placing an incision from the armpit to the elbow and by removing extra fat and skin. The excess fat from the inner thigh is removed by liposuction, the incision usually made between the groin and the upper thigh.
Porto Alegre Body Contouring - Risks
Every procedure has its risks. The most common complication of body lift is seroma formation. Other complications such as bleeding, infection or blood clots are relatively rare. The scars never completely disappear, but they fade with time and change their size. This can take several months until the scars take their final appearance.
Porto Alegre Body Contouring - Healing
This is a serious procedure, which takes some time to heal. Many people require 4-6 weeks before returning to their daily activities. You shouldn't exercise or lift heavy weight 6-8 weeks. The swelling usually completely disappears after 3 month. It is important to wear special garments to assure proper healing.
Other Body Contouring Procedures
All Body Procedures
Body Contouring porto-alegre (current)
porto-alegre Buttock Augmentation
porto-alegre Calf Augmentation
porto-alegre Liposuction
porto-alegre Body Contouring
More Porto Alegre info...
Porto Alegre Get around
The local bus system is widely spread, but hard to understand if you are not a local. The lines connect, in most of the cases, the neighborhoods to downtown. There are no maps available, neither signs and schedules at the bus stops. The best way to find out a certain line or route is to ask people at the stops or bus drivers. That's what local people do when they don't know which bus to take. But don´t worry, because the buses are clean, safe and fast.
There are plenty of taxis. They can be pricey, if compared to other towns, but they are also an easier and safer option to buses.
-
Porto Alegre Mid-range
Dado Tambor: Av. T?lio de Rose , 100
Le Bistrot: on winter try the excellent soups. But don´t miss the "nuttela cr?pe". Fernando Gomes, 58 - Phone: 3346-3812
Bistr? Torta de Sorvete: For taking a snack in the afternoon. Try the delicious and famous ice cream pie, the one that give its name to the house. Padre Cahgas, 217 - Phone: 3346-1616 -
Plastic Surgery News...
- Despite steps taken by CMS over the past year, Medicare Advantage plans continue to engage in aggressive marketing practices, according to witnesses at a Senate Finance Committee hearing on Thursday, CQ HealthBeat reports. Witnesses recommended that Congress give states joint authority with the federal government to regulate marketing tactics used by health insurers.
- The European Medicines Agency’s (EMEA) has issued a public statement on the risk of peripheral neuropathy with Sebivo® (telbivudine). The statement is given below (direct from source):
The European Medicines Agency’s (EMEA) Committee for Medicinal Products for Human Use (CHMP) has recommended that new warnings be included in the product information for Sebivo (telbivudine), from Novartis Europharm Ltd. This warning is intended to inform doctors about the risk of peripheral neuropathy in patients with chronic hepatitis B who are being treated with Sebivo.
Doctors are advised to monitor patients carefully for signs of peripheral neuropathy and to reconsider treatment options if they suspect that a patient is developing peripheral neuropathy. Sebivo is indicated for the treatment of chronic hepatitis B in adult patients with compensated liver disease and evidence of viral replication, persistently elevated serum alanine aminotransferase (ALT) levels and histological evidence of active inflammation and/or fibrosis as monotherapy only.
Cases of peripheral neuropathy have been uncommonly reported in patients treated with telbivudine as monotherapy. In a clinical trial investigating the combination therapy of telbivudine 600 mg daily with pegylated interferon alfa-2a 180 mcg once weekly, an increased risk of peripheral neuropathy was observed.
The CHMP, after evaluating the available data, has recommended the inclusion of the following warning in the product information for Sebivo:
Peripheral neuropathy has been uncommonly reported in telbivudine-treated patients. If peripheral neuropathy is suspected, treatment with telbivudine should be reconsidered (see section 4.8).
An increased risk of peripheral neuropathy has been observed when telbivudine and pegylated interferon alfa-2a are co-administered (see section 4.5). Such increased risk cannot be excluded for other interferons alfa (pegylated or standard). Moreover, the benefit of this combination of telbivudine with interferon alfa (pegylated or standard) is not currently established.
The statement can be accessed at the above link.